6-Oxo-Palonosetron

6-Oxo-Palonosetron Basic information
Product Name:6-Oxo-Palonosetron
Synonyms:6-Oxo-Palonosetron;6-Oxo-(S,S)-Palonosetron (~90%);6-Oxo-(S,S)-Palonosetron;(S)-2-((S)-quinuclidin-3-yl)-3,3a,4,5-tetrahydro-1H-benzo[de]isoquinoline-1,6(2H)-dione;Palonosetron Impurity 49;1H-Benz[de]isoquinoline-1,6(2H)-dione, 2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-3,3a,4,5-tetrahydro-, (3aS)-
CAS:848074-10-2
MF:C19H22N2O2
MW:310.39
EINECS:
Product Categories:
Mol File:848074-10-2.mol
6-Oxo-Palonosetron Structure
6-Oxo-Palonosetron Chemical Properties
Boiling point 502.5±50.0 °C(Predicted)
density 1.31±0.1 g/cm3(Predicted)
solubility Methanol (Slightly)
form Gel
pka9.62±0.33(Predicted)
color Very Dark Yellow
Safety Information
MSDS Information
6-Oxo-Palonosetron Usage And Synthesis
Uses6-Oxo-(S,S)-Palonosetron is an impurity of (S,S)-Palonosetron (P165800), a serotonin 5-HT3 receptor antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). Antiemetic.
6-Oxo-Palonosetron Preparation Products And Raw materials
PLSQ-001 TM4-QJ 5,6,7,8-Tetrahydronaphthalene-1-carboxylic acid N,N-Diethyl-5,6,7,8-tetrahydronaphthalene-1-carboxamide (1S)-N-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-1,2,3,4-tetrahydro-1-naphthalenecarboxaMide-d1 (3S)-AMinoquinuclidine-D1 Dihydrochloride 6-Hydroxy Palonosetron 2-((S)-Quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline (S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamide 2H-Naphtho[1,8-bc]furan-2-one, 6,7,8,8a-tetrahydro- (R,S)-Palonosetron Hydrochloride (6R)-Hydroxy (R,S)-Palonosetron (3S)-3-deuterio-N-[dideuterio-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]methyl]-1-azabicyclo[2.2.2]octan-3-amine (6S)-Hydroxy (S,S)-Palonosetron 1-Naphthalenecarboxylic acid, 5,6,7,8-tetrahydro-8-hydroxy- (6R)-Hydroxy (S,S)-Palonosetron (S)-3-Aminoquinuclidine dihydrochloride (S)-quinuclidin-3-aMine N-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-5,6-dihydro-1-Naphthalenecarboxamide

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.